Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Riccardo Turrini

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
International Journal of Hematology|February 22, 2011
Immunotherapy for EBV-associated malignanciesAnna Merlo, Riccardo Turrini, Riccardo Dolcetti, et al.
Cancer Immunology, Immunotherapy : CII|August 12, 2011
Differential down-modulation of HLA class I and II molecule expression on human tumor cell lines upon in vivo transferRiccardo Turrini, Anna Merlo, Riccardo Dolcetti, et al.
International Reviews of Immunology|July 20, 2010
Role of CD4+ cytotoxic T lymphocytes in the control of viral diseases and cancerDebora Martorelli, Elena Muraro, Anna Merlo, et al.
Expert Opinion on Biological Therapy|August 13, 2008
Adoptive cell therapy against EBV-related malignancies: a survey of clinical resultsAnna Merlo, Riccardo Turrini, Riccardo Dolcetti, et al.
Journal of Translational Medicine|November 25, 2010
Impact of γ-chain cytokines on EBV-specific T cell culturesAnna Merlo, Riccardo Turrini, Cristina Trento, et al.
Oncoimmunology|May 17, 2017
TIE-2 expressing monocytes in human cancersRiccardo Turrini, Angélique Pabois, Ioannis Xenarios, et al.
Haematologica|April 28, 2010
The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disordersAnna Merlo, Riccardo Turrini, Riccardo Dolcetti, et al.
Clinical & Developmental Immunology|February 10, 2012
Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virus-driven disordersDebora Martorelli, Elena Muraro, Anna Merlo, et al.
Current Oncology (Toronto, Ont.)|January 27, 2026
Parenchymal-Sparing Strategy in Colorectal Liver Metastases: A Single-Center ExperienceEleonora Pozzi, Giuliano La Barba, Fabrizio D'Acapito, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|March 18, 2025
Impact of RAS, BRAF mutations and microsatellite status in peritoneal metastases from colorectal cancer treated with cytoreduction + HIPEC: scoping reviewValentina Zucchini, Fabrizio D'Acapito, Ilario Giovanni Rapposelli, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
International Journal of Hematology|February 22, 2011
Immunotherapy for EBV-associated malignanciesAnna Merlo, Riccardo Turrini, Riccardo Dolcetti, et al.
Cancer Immunology, Immunotherapy : CII|August 12, 2011
Differential down-modulation of HLA class I and II molecule expression on human tumor cell lines upon in vivo transferRiccardo Turrini, Anna Merlo, Riccardo Dolcetti, et al.
International Reviews of Immunology|July 20, 2010
Role of CD4+ cytotoxic T lymphocytes in the control of viral diseases and cancerDebora Martorelli, Elena Muraro, Anna Merlo, et al.
Expert Opinion on Biological Therapy|August 13, 2008
Adoptive cell therapy against EBV-related malignancies: a survey of clinical resultsAnna Merlo, Riccardo Turrini, Riccardo Dolcetti, et al.
Journal of Translational Medicine|November 25, 2010
Impact of γ-chain cytokines on EBV-specific T cell culturesAnna Merlo, Riccardo Turrini, Cristina Trento, et al.
Oncoimmunology|May 17, 2017
TIE-2 expressing monocytes in human cancersRiccardo Turrini, Angélique Pabois, Ioannis Xenarios, et al.
Haematologica|April 28, 2010
The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disordersAnna Merlo, Riccardo Turrini, Riccardo Dolcetti, et al.
Clinical & Developmental Immunology|February 10, 2012
Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virus-driven disordersDebora Martorelli, Elena Muraro, Anna Merlo, et al.
Current Oncology (Toronto, Ont.)|January 27, 2026
Parenchymal-Sparing Strategy in Colorectal Liver Metastases: A Single-Center ExperienceEleonora Pozzi, Giuliano La Barba, Fabrizio D'Acapito, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|March 18, 2025
Impact of RAS, BRAF mutations and microsatellite status in peritoneal metastases from colorectal cancer treated with cytoreduction + HIPEC: scoping reviewValentina Zucchini, Fabrizio D'Acapito, Ilario Giovanni Rapposelli, et al.
Pageof 3